No Data
No Data
No Data
No Data
No Data
國藥控股:年度報告2023
Futu News17minutes ago · Announcements
國藥控股:公告 國藥股份截至2024年3月31日止第一季度之 主要未經審核會計數據和財務指標
Futu NewsApr 25 09:17 ET · Announcements
Sinopharm Holdings (01099): Sinopharm (000028.SZ) net profit of about 389 million yuan in the first quarter increased 7.33% year-on-year
Sinopharm Holdings (01099) announced Sinopharm's (000028.SZ) results for the first quarter of 2024, operating...
Zhitong FinanceApr 25 06:03 ET
國藥控股:公告 國藥一致截至2024年3月31日止第一季度之 主要未經審核會計數據和財務指標
Futu NewsApr 25 06:00 ET · Announcements
Hong Kong Stock Concept Tracking | The 2024 trend of mergers and acquisitions of pharmaceutical distribution companies is expected to further accelerate leading state-owned enterprises to attract attention (with concept stocks)
The trend of mergers and acquisitions of domestic pharmaceutical distribution companies is expected to accelerate further, and the concentration of leaders may further increase
Zhitong FinanceApr 25 01:46 ET
SDIC Securities: The industry is heavily state-owned capital, and the trend of mergers and acquisitions of pharmaceutical distribution companies is expected to accelerate further in 24 years
The new round of state-owned enterprise reform also emphasizes specialized integration in the medical and health sector. The pharmaceutical distribution industry is heavily state-owned and driven by superposition policies. At the time point of 2024, the trend of mergers and acquisitions of domestic pharmaceutical distribution companies is expected to further accelerate.
Zhitong FinanceApr 24 23:22 ET
No Data
No Data